{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:22Z","timestamp":1791593842236,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-024452"],"award-info":[{"award-number":["MJFF-024452"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71555-4","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T01:02:10Z","timestamp":1726016530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Understanding what aspects of Parkinson\u2019s disease matter most to patients and families"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-9183","authenticated-orcid":false,"given":"Jennifer R.","family":"Mammen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirinda","family":"Tyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Cadorette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"71555_CR1","doi-asserted-by":"crossref","unstructured":"USDHHS, Patient-focused drug development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments (Guidance 3), https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-selecting-developing-or-modifying-fit-purpose-clinical-outcome. (2022).","DOI":"10.1007\/s40271-022-00607-6"},{"issue":"4","key":"71555_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JPD-225122","volume":"13","author":"J Mammen","year":"2023","unstructured":"Mammen, J. et al. Mapping meaningful symptoms and impacts of disease to digital outcome measures. J. Parkinsons Dis. 13(4), 589\u2013607. https:\/\/doi.org\/10.3233\/JPD-225122 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"71555_CR3","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis, M. et al. Parkinson\u2019s disease symptoms: The patient\u2019s perspective. Mov. Disord. 25, 1646\u20131651 (2010).","journal-title":"Mov. Disord."},{"key":"71555_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JPD-202346","volume":"11","author":"RJ Port","year":"2021","unstructured":"Port, R. J. et al. People with Parkinson\u2019s disease: What symptoms do they most want to improve and how does this change with disease duration?. J. Parkinsons Dis. 11, 715\u2013724 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"71555_CR5","unstructured":"USDHHS, Patient-focused drug development: Methods to identify what is important to patients (Guidance 2), https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-methods-identify-what-important-patients. (2022)."},{"key":"71555_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40900-018-0093-3","volume":"4","author":"M Chalasani","year":"2018","unstructured":"Chalasani, M., Vaidya, P. & Mullin, T. Enhancing the incorporation of the patient\u2019s voice in drug development and evaluation. Res. Involv. Engagem. 4, 10 (2018).","journal-title":"Res. Involv. Engagem."},{"key":"71555_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JPD-239901","volume":"13","author":"K McFarthing","year":"2023","unstructured":"McFarthing, K. et al. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2023 update. J. Parkinsons Dis. 13, 427\u2013439 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"71555_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12916-023-02933-4","volume":"21","author":"AD Geerlings","year":"2023","unstructured":"Geerlings, A. D. et al. Caregiver burden in Parkinson\u2019s disease: A mixed-methods study. BMC Med. 21, 247 (2023).","journal-title":"BMC Med."},{"key":"71555_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14802\/jmd.20079","volume":"14","author":"M Lubomski","year":"2021","unstructured":"Lubomski, M., Davis, R. L. & Sue, C. M. Health-related quality of life for Parkinson\u2019s disease patients and their caregivers. J. Mov. Disord. 14, 42\u201352 (2021).","journal-title":"J. Mov. Disord."},{"key":"71555_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/13607863.2016.1247414","volume":"21","author":"R Theed","year":"2017","unstructured":"Theed, R., Eccles, F. & Simpson, J. Experiences of caring for a family member with Parkinson\u2019s disease: A meta-synthesis. Aging Ment. Health 21, 1007\u20131016 (2017).","journal-title":"Aging Ment. Health"},{"key":"71555_CR11","doi-asserted-by":"crossref","unstructured":"(2013) World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects. JAMA J. Am. Med. Assoc. 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"71555_CR12","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4377805\/v1","author":"J Mammen","year":"2024","unstructured":"Mammen, J. et al. A consensus conceptual model of early Parkinson\u2019s disease. Res. Square. https:\/\/doi.org\/10.21203\/rs.3.rs-4377805\/v1 (2024).","journal-title":"Res. Square."},{"key":"71555_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu, H. User\u2019s guide to correlation coefficients. Turk. J. Emerg. Med. 18, 91\u201393 (2018).","journal-title":"Turk. J. Emerg. Med."},{"key":"71555_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien, B. C., Harris, I. B., Beckman, T. J., Reed, D. A. & Cook, D. A. Standards for reporting qualitative research: A synthesis of recommendations. Acad. Med. 89, 1245\u20131251 (2014).","journal-title":"Acad. Med."},{"key":"71555_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JPD-225068","volume":"13","author":"J Mammen","year":"2023","unstructured":"Mammen, J. et al. Relative meaningfulness and impacts of symptoms in people with early-stage Parkinson\u2019s disease. J. Parkinsons Disease 13, 619\u2013632 (2023).","journal-title":"J. Parkinsons Disease"},{"key":"71555_CR16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s40120-022-00375-3","volume":"11","author":"T Morel","year":"2022","unstructured":"Morel, T. et al. Patient experience in early-stage Parkinson\u2019s disease: Using a mixed methods analysis to identify which concepts are cardinal for clinical trial outcome assessment. Neurol. Ther. 11, 1319\u20131340 (2022).","journal-title":"Neurol. Ther."},{"key":"71555_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JPD-202457","volume":"12","author":"H Staunton","year":"2022","unstructured":"Staunton, H. et al. A patient-centered conceptual model of symptoms and their impact in early Parkinson\u2019s disease: A qualitative study. J. Parkinsons Disease 12, 137\u2013151 (2022).","journal-title":"J. Parkinsons Disease"},{"key":"71555_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3233\/JPD-225083","volume":"13","author":"C Marras","year":"2023","unstructured":"Marras, C. et al. What patients say: Large-scale analyses of replies to the Parkinson\u2019s disease patient report of problems (PD-PROP). J. Parkinsons Dis. 13, 757\u2013767 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"71555_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/ane.12010","volume":"127","author":"B Muller","year":"2013","unstructured":"Muller, B. et al. Autonomic symptoms and dopaminergic treatment in de novo Parkinson\u2019s disease. Acta Neurologica Scandinavica 127, 290\u2013294 (2013).","journal-title":"Acta Neurologica Scandinavica"},{"key":"71555_CR20","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1007\/s00415-021-10519-4","volume":"268","author":"M Siciliano","year":"2021","unstructured":"Siciliano, M. et al. Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson\u2019s disease. J. Neurol. 268, 3444\u20133455 (2021).","journal-title":"J. Neurol."},{"key":"71555_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/08919887211023592","volume":"35","author":"J Naisby","year":"2022","unstructured":"Naisby, J. et al. A survey of people with Parkinson\u2019s and their carers: The management of pain in Parkinson\u2019s. J. Geriatr. Psychiatry Neurol. 35, 613\u2013621 (2022).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"71555_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208028","volume":"102","author":"MH Tosin","year":"2024","unstructured":"Tosin, M. H., Goetz, C. G. & Stebbins, G. T. Patient with Parkinson disease and care partner perceptions of key domains affecting health-related quality of life: Systematic review. Neurology 102, e208028 (2024).","journal-title":"Neurology"},{"key":"71555_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.577435","volume":"12","author":"J Wilson","year":"2020","unstructured":"Wilson, J. et al. Gait progression over 6 years in Parkinson\u2019s disease: Effects of age, medication, and pathology. Front. Aging Neurosci. 12, 577435 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"71555_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnins.2021.761817","volume":"15","author":"CX Pan","year":"2021","unstructured":"Pan, C. X. et al. Subjective cognitive complaints in newly-diagnosed Parkinson\u2019s disease with and without mild cognitive impairment. Front. Neurosci. 15, 8 (2021).","journal-title":"Front. Neurosci."},{"key":"71555_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fneur.2022.998103","volume":"13","author":"MRE Koh","year":"2022","unstructured":"Koh, M. R. E. et al. Poor sleep quality is associated with fatigue and depression in early Parkinson\u2019s disease: A longitudinal study in the PALS cohort. Front. Neurol. 13, 9 (2022).","journal-title":"Front. Neurol."},{"key":"71555_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","volume":"39","author":"HN Costa","year":"2023","unstructured":"Costa, H. N., Esteves, A. R., Empadinhas, N. & Cardoso, S. M. Parkinson\u2019s disease: A multisystem disorder. Neurosci. Bull. 39, 113\u2013124 (2023).","journal-title":"Neurosci. Bull."},{"key":"71555_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.parkreldis.2013.07.010","volume":"19","author":"B Muller","year":"2013","unstructured":"Muller, B., Assmus, J., Herlofson, K., Larsen, J. P. & Tysnes, O. B. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson\u2019s disease. Parkinsonism Related Disord. 19, 1027\u20131032 (2013).","journal-title":"Parkinsonism Related Disord."},{"key":"71555_CR28","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.21037\/apm.2019.10.01","volume":"9","author":"ZA Macchi","year":"2020","unstructured":"Macchi, Z. A. et al. Patient and caregiver characteristics associated with caregiver burden in Parkinson\u2019s disease: A palliative care approach. Ann. Palliat. Med. 9, S24\u2013S33 (2020).","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"71555_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/brainsci12010111","volume":"12","author":"K Rosqvist","year":"2021","unstructured":"Rosqvist, K., Schrag, A., Odin, P. & The CLaSP Consortium. Caregiver burden and quality of life in late stage Parkinson\u2019s disease. Brain Sci. 12(1), 111. https:\/\/doi.org\/10.3390\/brainsci12010111 (2022).","journal-title":"Brain Sci."},{"key":"71555_CR30","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3233\/JPD-212612","volume":"11","author":"QY Tan","year":"2021","unstructured":"Tan, Q. Y. et al. The experiences of treatment burden in people with Parkinson\u2019s disease and their caregivers: A systematic review of qualitative studies. J. Parkinsons Dis. 11, 1597\u20131617 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"71555_CR31","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.21037\/apm.2020.02.04","volume":"9","author":"S Fox","year":"2020","unstructured":"Fox, S., Azman, A. & Timmons, S. Palliative care needs in Parkinson\u2019s disease: Focus on anticipatory grief in family carers. Ann. Palliat. Med. 9, S34\u2013S43 (2020).","journal-title":"Ann. Palliat. Med."},{"key":"71555_CR32","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1111\/jocn.16636","volume":"32","author":"MV Navarta-Sanchez","year":"2023","unstructured":"Navarta-Sanchez, M. V. et al. Perspectives of people with Parkinson\u2019s disease and family carers about disease management in community settings: A cross-country qualitative study. J. Clin. Nurs. 32, 5201\u20135218 (2023).","journal-title":"J. Clin. Nurs."},{"key":"71555_CR33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.gerinurse.2021.10.010","volume":"42","author":"BM Jika","year":"2021","unstructured":"Jika, B. M., Khan, H. T. A. & Lawal, M. Exploring experiences of family caregivers for older adults with chronic illness: A scoping review. Geriatr. Nurs. 42, 1525\u20131532 (2021).","journal-title":"Geriatr. Nurs."},{"key":"71555_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/jgs.12841","volume":"62","author":"JM Sautter","year":"2014","unstructured":"Sautter, J. M. et al. Caregiver experience during advanced chronic illness and last year of life. J. Am. Geriatr. Soc. 62, 1082\u20131090 (2014).","journal-title":"J. Am. Geriatr. Soc."},{"key":"71555_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chbr.2022.100206","volume":"7","author":"M-J Wu","year":"2022","unstructured":"Wu, M.-J., Zhao, K. & Fils-Aime, F. Response rates of online surveys in published research: A meta-analysis. Comput. Hum. Behav. Rep. 7, 100206 (2022).","journal-title":"Comput. Hum. Behav. Rep."},{"key":"71555_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00019442-200405000-00006","volume":"12","author":"LP Sands","year":"2004","unstructured":"Sands, L. P., Ferreira, P., Stewart, A. L., Brod, M. & Yaffe, K. What Explains differences between dementia patients\u2019 and their caregivers\u2019 ratings of patients\u2019 quality of life?. Am. J. Geriatr. Psychiatry 12, 272\u2013280 (2004).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"71555_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12357","volume":"8","author":"RL Nosheny","year":"2022","unstructured":"Nosheny, R. L. et al. The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations. Alzheimers Dement (N Y) 8, e12357 (2022).","journal-title":"Alzheimers Dement (N Y)"},{"key":"71555_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13195-019-0544-6","volume":"11","author":"MM Nuno","year":"2019","unstructured":"Nuno, M. M., Gillen, D. L., Grill, J. D. & Alzheimer\u2019s Disease Cooperative, S. Study partner types and prediction of cognitive performance: Implications to preclinical Alzheimer\u2019s trials. Alzheimers Res. Ther. 11, 92 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"71555_CR39","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1046\/j.1532-5415.2003.51514.x","volume":"51","author":"VG Wadley","year":"2003","unstructured":"Wadley, V. G., Harrell, L. E. & Marson, D. C. Self- and informant report of financial abilities in patients with Alzheimer\u2019s disease: Reliable and valid?. J. Am. Geriatr. Soc. 51, 1621\u20131626 (2003).","journal-title":"J. Am. Geriatr. Soc."},{"key":"71555_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal alpha-synuclein disease: Towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71555-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71555-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71555-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T01:04:16Z","timestamp":1726016656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71555-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71555"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71555-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no financial or non-financial competing interests for the study. JRM has consulted for and received research funding from the Michael J Fox Foundation for Parkinson\u2019s Research. JLA Has received honoraria from Huntington Study Group, research support from National Institutes of Health, The Michael J Fox Foundation for Parkinson\u2019s Research, Biogen, Safra Foundation, Empire Clinical Research Investigator Program, and consultancy fees from VisualDx.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21171"}}